Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
CNS Drugs
Published in: CNS Drugs 4/2006

01-04-2006 | Leading Article

Aromatherapy in the Management of Psychiatric Disorders

Clinical and Neuropharmacological Perspectives

Authors: Dr Nicolette Perry, Elaine Perry

Published in: CNS Drugs | Issue 4/2006

Login to get access

Abstract

Aromatherapy is currently used worldwide in the management of chronic pain, depression, anxiety, some cognitive disorders, insomnia and stress-related disorders. Although essential oils have been used, reputedly effectively, for centuries as a traditional medicine, there is very little verified science behind this use. The pharmacology of the essential oils and/or their single chemical constituents, therefore, remains largely undiscovered. However, accumulating evidence that inhaled or dermally applied essential oils enter the blood stream and, in relevant molecular, cellular or animal models, exert measurable psychological effects, indicates that the effects are primarily pharmacological.
This review includes evidence from the limited number of clinical trials that have been published of ‘psychoaromatherapy’ in relation to psychiatric disorders, together with evidence from mechanistic, neuropharmacological studies of the effects of essential oils in relevant in vitro and in vivo models. It is concluded that aromatherapy provides a potentially effective treatment for a range of psychiatric disorders. In addition, taking into account the available information on safety, aromatherapy appears to be without the adverse effects of many conventional psychotropic drugs. Investment in further clinical and scientific research is clearly warranted.
Footnotes
1
This review was submitted in May 2004 and accepted in March 2005.
 
Literature
1.
Price S, Price L. Aromatherapy for health professionals. Edinburgh: Churchill Livingstone Press, 1995
2.
Tisserand R, Balacs T. Essential oil safety: a guide for health care professionals. Edinburgh: Churchill Livingstone, 1995
3.
Lawless J. The complete illustrated guide to aromatherapy. New York: Barnes & Noble, 1997
4.
Buckle J. Aromatherapy for health professionals. Beginnings 2003; 23: 6–7PubMed
5.
Thomas DV. Aromatherapy: mythical, magical, or medicinal? Holist Nurs Pract 2002; 16: 8–16PubMed
6.
Bowles EJ. The basic chemistry of aromatherapeutic essential oils. Sydney: Pirie Printers, 2000
7.
Welsh C. Touch with oils: a pertinent part of holistic hospice care. Am J Hosp Palliat Care 1997 Jan/Feb; 14(1): 42–4PubMedCrossRef
8.
Urba SG. Nonpharmacologic pain management in terminal care. Clin Geriatr Med 1996; 12: 301–11PubMed
9.
Walsh D. Using aromatherapy in the management of psoriasis. Nurs Stand 1996; 11(13–15): 53–6PubMed
10.
Heuberger E, Hongratanaworakit T, Bohm C, et al. Effects of chiral fragrances on human autonomic nervous system parameters and self-evaluation. Chem Senses 2001; 26: 281–92PubMedCrossRef
11.
Frey WH. Bypassing the blood-brain barrier to deliver therapeutic agents to the brain and spinal cord. Drug Deliv Tech 2002; 2: 46–9
12.
Born J, Lange T, Kern W, et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 2002; 5: 514–6PubMedCrossRef
13.
Rochefort C, Gheusi G, Vincent JD, et al. Enriched odor exposure increases the number of newborn neurons in the adult olfactory bulb and improves odor memory. J Neurosci 2002; 22: 2679–89PubMed
14.
Limke TL, Rao MS. Neural stem cell therapy in the aging brain: pitfalls and possibilities. Hematother Stem Cell Res 2003; 12: 615–23CrossRef
15.
Taupin P. Adult neurogenesis in the mammalian central nervous system: functionality and potential clinical interest. Med Sci Monit 2005; 11: LE15
16.
17.
Buckle J. The role of aromatherapy in nursing care. Nurs Clin North Am 2001; 36: 57–72PubMed
18.
Henry J, Rusius CW, Davies M, et al. Lavender for night sedation of people with dementia. Int J Aromather 1994; 5(2): 28–30
19.
Brooker DJ, Snape M, Johnson E, et al. Single case evaluation of the effects of aromatherapy and massage on disturbed behaviour in severe dementia. Br J Clin Psychol 1997; 36: 287–96PubMedCrossRef
20.
Kilstoff K, Chenoweth L. New approaches to health and well-being for dementia day-care clients, family carers and day-care staff. Int J Nurs Pract 1998; 4: 70–83PubMedCrossRef
21.
Mitchell S. Aromatherapy’s effectiveness in disorders associated with dementia. Int J Aromather 1993; 4: 20–3
22.
Smallwood J, Brown R, Coulter F, et al. Aromatherapy and behaviour disturbances in dementia: a randomized controlled trial. Int J Geriatr Psychiatry 2001; 16: 1010–3PubMedCrossRef
23.
Holmes C, Hopkins V, Hensford C, et al. Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study. Int Geriatr Psychiatry 2002; 17: 305–8CrossRef
24.
Ballard CG, O’Brien JT, Reichelt K, et al. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 2002; 63: 553–8PubMedCrossRef
25.
Bowles-Dilys EJ, Griffiths M, Quirk L, et al. Effects of essential oils and touch on resistance to nursing care procedures and other dementia-related behaviours in a residential care facility. Int J Aromather 2002; 12: 1–8
26.
Beshara MC, Giddings D. Use of plant essential oils in treating agitation in a dementia unit: 10 case studies. Int J Aromather 2003; 12: 207–12CrossRef
27.
Gray SG, Clair AA. Influence of aromatherapy on medication administration to residential-care residents with dementia and behavioral challenges. Am J Alzheimers Dis Other Demen 2002; 17: 169–74PubMedCrossRef
28.
Perry NS, Houghton PJ, Sampson J, et al. In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer’s disease. J Pharm Pharmacol 2001; 53: 1347–56
29.
Perry NSL, Bollen C, Perry EK, et al. Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav 2003; 75: 651–9PubMedCrossRef
30.
Tildesley NT, Kennedy DO, Perry EK, et al. Salvialavandulaefolia (Spanish sage) enhances memory in healthy young volunteers. Pharmacol Biochem Behav 2003; 75: 669–74PubMedCrossRef
31.
32.
Ludvigson HW, Rottman TR. Effects of ambient odors of lavender and cloves on cognition, memory, affect and mood. Chem Senses 1989; 14: 525–36CrossRef
33.
Moss M, Cook J, Wesnes K, et al. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. Int J Neurosci 2003; 13: 15–38CrossRef
34.
Motomura N, Sakurai A, Yotsuya Y. Reduction of mental stress with lavender odorant. Percept Mot Skills 2001; 93: 713–8PubMedCrossRef
35.
Thorgrimsen L, Spector A, Wiles A, et al. Aroma therapy for dementia. Cochrane Database Syst Rev 2003; (3): CD003150
36.
37.
Ferry P, Johnson M, Wallis P. Use of complementary therapies and non-prescribed medication in patients with Parkinson’s disease. Postgrad Med J 2002; 78: 612–4PubMedCrossRef
38.
Hicks G. Aromatherapy as an adjunct to care in a mental health day hospital [letter]. J Psychiatr Ment Health Nurs 1998; 5: 317PubMedCrossRef
39.
The complete German commission E monographs: therapeutic guide to herbal medicines. Austin (TX): American Botanical Council, 1999
40.
Hardy M, Kirk-Smith MD, Stretch DD. Replacement of drug treatment for insomnia by ambient odour. Lancet 1995; 346: 701PubMedCrossRef
41.
Cannard G. The effect of aromatherapy in promoting relaxation and stress reduction in a general hospital. Complement Ther Nurs Midwifery 1996; 2: 38–40PubMedCrossRef
42.
Schultz V, Hubner WD, Plock M. Clinical trials with phytopsychopharmacological agents [letter]. Phytomedicine 1997; 346: 701
43.
Connell FEA, Tan G, Gupta I, et al. Can aromatherapy promote sleep in elderly hospitalized patients? Geriatr Today: J Can Geriatr Soc 2001; 4(4): 191–5
44.
Atanassova-Shopova S, Roussinov KS. On certain central neurotropic effects of lavender essential oil. Izv Inst Fiziol (Sofiia) 1970; 13: 69–77
45.
Edge J. A pilot study addressing the effect of aromatherapy massage on mood, anxiety and relaxation in adult mental health. Complement Ther Nurs Midwifery 2003; 9: 90–7PubMedCrossRef
46.
Dunn C, Sleep J, Collett D. Sensing an improvement: an experimental study to evaluate the use of aromatherapy, massage and periods of rest in an intensive care unit. Adv Nurs 1995; 21: 34–40CrossRef
47.
Lehrner J, Eckersberger C, Walla P, et al. Ambient odor of orange in a dental office reduces anxiety and improves mood in female patients. Physiol Behav 2000; 71: 83–6PubMedCrossRef
48.
Hadfield N. The role of aromatherapy massage in reducing anxiety in patients with malignant brain tumours. Int J Palliat Nurs 2001; 7: 279–85PubMed
49.
Louis M, Kowalski SD. Use of aromatherapy with hospice patients to decrease pain, anxiety, and depression and to promote an increased sense of well-being. Am J Hosp Palliat Care 2002; 19: 381–6PubMedCrossRef
50.
Graham PH, Browne L, Cox H, et al. Inhalation aromatherapy during radiotherapy: results of a placebo-controlled double-blind randomized trial. J Clin Oncol 2003; 21: 2372–6PubMedCrossRef
51.
Wiebe E. A randomized trial of aromatherapy to reduce anxiety before abortion. Eff Clin Pract 2000; 3: 166–9PubMed
52.
Cooke B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract 2000; 50: 493–6PubMed
53.
Roberts A, Williams JM. The effect of olfactory stimulation on fluency, vividness of imagery and associated mood: a preliminary study. Br J Med Psychol 1992; 65: 197–9PubMedCrossRef
54.
Komori T, Fujiwara R, Tanida M, et al. Effects of citrus fragrance on immune function and depressive states. Neuroim-munomodulation 1995; 2: 174–80
55.
Itai T, Amayasu H, Kuribayashi M, et al. Psychological effects of aromatherapy on chronic hemodialysis patients. Psychiatry Clin Neurosci 2000; 54: 393–7PubMedCrossRef
56.
Diego MA, Jones NA, Field T, et al. Aromatherapy positively affects mood, EEG patterns of alertness and math computations. Int J Neurosci 1998; 96: 217–24PubMedCrossRef
57.
Betts T. Use of aromatherapy (with or without hypnosis) in the treatment of intractable epilepsy: a two-year follow-up study. Scizure 2003; 12: 534–8CrossRef
58.
Lindsay WR, Pitcaithly D, Geelen N, et al. A comparison of the effects of four therapy procedures on concentration and responsiveness in people with profound learning disabilities. J Intellect Disabil Res 1997; 41: 201–7PubMedCrossRef
59.
Buckle J. Use of aromatherapy as a complementary treatment for chronic pain. Altern Ther Health Med 1999; 5: 42–51PubMed
60.
Tisserand R, Balacs T. Essential oil safety: a guide for health care professionals. Glasgow: Harcourt, 1999
61.
62.
Aliye UC, Bishop WP, Sanders KD. Camphor hepatotoxicity. South Med J 2000; 93(6): 596–8
63.
Jimenez JF, Brown AL, Arnold WC, et al. Chronic camphor ingestion mimicking Reye’s Syndrome. Gastroenterology 1983; 84: 394–8PubMed
64.
Kovar KA, Gropper B, Friess D, et al. Blood levels of 1,8-cineole and locomotor activity of mice after inhalation and oral administration of rosemary oil. Planta Med 1987; 53: 315–8PubMedCrossRef
65.
Burkard PR, Burkhardt K, Haenggeli DA, et al. Plant-induced seizures: reappearance of an old problem. J Neurol 1999; 246(8): 667–70CrossRef
66.
67.
Cavanagh HMA, Wilkinson JM. Biological activities of lavender essential oil. Phytother Res 2002; 16: 301–8PubMedCrossRef
68.
Ballard C, O’Brien J. Treating behavioural and psychological signs in Alzheimer’s disease. BMJ 1999; 319: 138–9PubMedCrossRef
69.
Tune LE, Steele C, Cooper T. Neuroleptic drugs in the management of behavioral symptoms of Alzheimer’s disease. Psychiatr Clin North Am 1991; 14: 353–73PubMed
70.
Jeste DV, Gilbert PL, McAdams LA, et al. Considering neuroleptic maintenance and taper on a continuum: need for individual rather than dogmatic approach. Arch Gen Psychiatry 1995; 52: 209–12PubMedCrossRef
71.
McShane R, Keene J, Gedling K, et al. Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. BMJ 1997; 314: 266–70PubMedCrossRef
72.
Buchbauer G, Jirovetz L, Jager W. Aromatherapy: evidence for sedative effects of the essential oil of lavender after inhalation. Z Naturforsch 1991; 46c: 1067–72
73.
Buchbauer G, Jirovetz L, Jager W, et al. Fragrance compounds and essential oils with sedative effects upon inhalation. J Pharm Sci 1993; 82(6): 660–4PubMedCrossRef
74.
Fujiwara R, Komori T, Noda Y, et al. Effects of a long-term inhalation of fragrances on the stress-induced immunosuppression in mice. Neuroimmunomodulation 1998; 5: 318–22PubMedCrossRef
75.
Jirovetz L, Buchbauer G, Jager W, et al. Determination of lavender oil fragrance compounds in blood samples. Fresenius J Anal Chem 1990; 338: 922–3CrossRef
76.
Perry NS, Houghton PJ, Jenner P, et al. Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo. Phytomedicine 2002; 9(1): 48–51PubMedCrossRef
77.
Moreira MR, Cruz GM, Lopes MS, et al. Effects of terpineol on the compound action potential of the rat sciatic nerve. Braz J Med Biol Res 2001; 34: 1337–40PubMedCrossRef
78.
Umezu T. Behavioral effects of plant-derived essential oils in the Geller types conflict test in mice. Jpn J Pharmacol 2000; 83: 150–3PubMedCrossRef
79.
Yamada K, Mimaki Y, Sashida Y. Anticonvulsive effects of inhaling lavender oil vapour. Biol Pharm Bull 1994; 17: 359–60PubMedCrossRef
80.
Guillemain J, Rousseau A, Delaveau P. Effets neurodepresseurs de l’huile essentielle de Lavandula angustifolia Mill. Ann Pharm Fr 1989; 47(6): 337–43PubMed
81.
Buyukokuroglu ME, Gepdiremen A, Hacimuftuoglu A, et al. The effects of aqueous extract of Lavandula angustifolia flowers in glutamate-induced neurotoxicity of cerebellar granular cell culture of rat pups. J Ethnopharmacol 2003; 84: 91–4PubMedCrossRef
82.
Lis-Balchin M, Hart S. Studies on the mode of action of the essential oil of lavender (Lavandula angustifolia P. Miller). Phytother Res 1999; 13: 540–2PubMedCrossRef
83.
Ghelardini C, Galeotti N, Salvatore G, et al. Local anaesthetic activity of the essential oil of Lavandular angustifolia. Planta Med 1999; 65 (8)
84.
Fujiwara R, Komori T, Mitsuo Y. Psychoneuroimmunological benefits of aromatherapy. Int J Aromather 2002; 12(2): 78–82CrossRef
85.
Gilani AH, Aziz N, Khan MA, et al. Ethnopharmacological evaluation of the anticonvulsant, sedative and antispasmodic activities of Lavandula stoechas L. J Ethnopharmacol 2000; 71: 161–7PubMedCrossRef
86.
Elisabetsky E, Marschner J, Souza DO. Effects of linalool on glutamatergic system in the rat cerebral cortex. Neurochem Res 1995; 20(4): 461–5PubMedCrossRef
87.
Sugawara Y, Hino Y, Kawasaki M, et al. Alteration of perceived fragrance of essential oils in relation to type of work: a simple screening test for efficacy of aroma. Chem Senses 1999; 24: 415–21PubMedCrossRef
88.
Elisabetsky E, Silva Brum LF, Souza DO. Anticonvulsant properties of linalool in glutamate-related seizure models. Phytomedicine 1999; 6(2): 107–13PubMedCrossRef
89.
Silva Brum LF, Elisabetsky E, Souza D. Effects of linalool on [3H] MK801 and [3H] muscimol binding in mouse cortical membranes. Phytother Res 2001; 15: 422–5CrossRef
90.
Silva Brum LF, Emanuelli T, Souza DO, et al. Effects of linalool on glutamate release and uptake in mouse cortical synaptosomes. Neurochem Res 2001; 26(3): 191–4PubMedCrossRef
91.
Re L, Barocci S, Sonnino S, et al. Linalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junction. Pharmacol Res 2000; 42(1): 177–81PubMedCrossRef
92.
Komori T, Fujiwara R, Tanida M, et al. Potential antidepressant effects of lemon odor in rats. Eur Neuropsychopharmacol 1995; 5: 477–80PubMed
93.
Bowles JE. The basic chemistry of aromatherapeutic essential oils. 2nd ed. Sydney. Good Scents Aroma Pleasures, 2002
94.
Cho J, Kong JY, Jeong DY, et al. NMDA recepter-mediated neuroprotection by essential oils from the rhizomes of Acorusgramineus. Life Sci 2001; 68: 1567–73PubMedCrossRef
95.
Koo BS, Park KS, Ha JH, et al. Inhibitory effects of the fragrance inhalation of essential oil from Acorus gramineus on central nervous system. Biol Pharm Bull 2003; 26: 978–82PubMedCrossRef
96.
Perazzo FF, Carvalho JC, Carvalho JE, et al. Central properties of the essential oil and the crude ethanol extract from aerial parts of Artemisia annua L. Pharmacol Res 2003; 48(5): 497–502PubMedCrossRef
97.
Tsuchiya T, Tanida M, Uenoyama S, et al. Effects of olfactory stimulation with jasmin and its component chemicals on the duration of pentobarbital-induced sleep in mice. Life Sci 1992; 50: 1097–102PubMedCrossRef
98.
Kagawa D, Jokura H, Ochiai R, et al. The sedative effects and mechanism of action of cedrol inhalation with behavioral pharmacological evaluation. Planta Med 2003; 69: 637–41PubMedCrossRef
99.
Ortiz de Urbina AV, Martin ML, Montera MJ, et al. Sedating and antipyretic activity of the essential oil of Calaminthasylvatica subsp. Ascendens. J Ethnopharmacol 1989; 25: 165–71CrossRef
100.
do Vale TG, Furtado EC, SantosJr JG, et al. Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from Lippia alba (Mill.) n.e. Brown. Phytomed 2002; 9(8): 709–14CrossRef
101.
Umezu T. Anticonflict effects of plant-derived essential oils. Pharmacol Biochem Behav 1999; 64(1): 35–40PubMedCrossRef
102.
Umezu T, Ito H, Nagano K, et al. Anticonflict effects of rose oil and identification of its active constituents. Life Sci 2002; 72: 91–102PubMedCrossRef
103.
Carvalho-Freitas MI, Costa M. Anziolytic and sedative effects of extrats and essential oil of Cirtus aurantium L. Biol Pharm Bull 2002; 25: 1629–33PubMedCrossRef
104.
Occhiuto F, Limardi F, Circosta C. Effects of the non-volatile residue from the essential oil of Citrus bergamia on the central nervous system. Int J Pharmacog 1995; 33(3): 198–203CrossRef
105.
Pourgholami MH, Kamalinejad M, Javadi M, et al. Evaluation of the anticonvulsant activity of the essential oil of Eugenia caryophyllata in male mice. J Ethnopharmacol 1999; 64: 167–71PubMedCrossRef
106.
Sayyah M, Valizadeh J, Kamalinejad M. Anticonvulsant activity of the leaf essential oils of Laurus nobilis against pntylenetetrazole and maximal electroshock-induced seizures. Pytomed 2002; 9: 212–6CrossRef
107.
Yamada K, Miura T, Mimaki Y, et al. Effect of inhalation of chamomile oil vapour on plasma ACTH level in ovariectomized-rat under restriction stress. Biol Pham Bull 1996; 19: 1244–6CrossRef
108.
Abdul-Ghani AS, El-Lati SG, Suleiman AI, et al. Anticonvulsant effects of some Arab medicinal plants. Int J Crude Drug Res 1987; 24(1): 39–43
109.
Avallone R, Zanoli P, Puia G, et al. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem Pharmacol 2000; 59: 1387–94PubMedCrossRef
110.
Wake G, Court J, Pickering A, et al. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J Ethnopharmacol 2000; 69: 105–14PubMedCrossRef
111.
Soulimani R, Fleurentin J, Mortier F, et al. Neurotropic action of the hydroalcoholic extract of Meilssa officinalis in the mouse. Planta Med 1991; 57: 105–9PubMedCrossRef
112.
Soulimani R, Younos C, Fleurentin J, et al. Recherche de l’activite biologique de Melissa Officinalis I. sur le systeme nerveux central del la souris in vivo et le duodenum de rat in vitro. Plantes Medicinales et Phytotherapie 1993; 2: 77–85
113.
Tittel G, Wagner H, Bos R. Uver due chemnische Zusammensetzung von Melissenolen. Hipprakrates Verlag GmBH 1982; 46
114.
Coleta M, Campos MG, Cotrim MD, et al. Comparative evaluation of Melissa officinalis L, Tilia europaea L, Passifloraedulis Sims, and Hypericum perforatum L. in the elevated plus maze anxiety test. Pharmacopsychiatry 2001; 34: S20–1PubMedCrossRef
115.
Tagashira M, Ohtake Y. A new antioxidative 1,3-benzodioxole from Melissa officinalis. Planta Med 1998; 64: 555–8CrossRef
116.
Pérez Raya MD, Utrilla MP, Navarro MC, et al. CNS activity of Mentha rotundifolia and Mentha longifolia essential oil in mice and rats. Phytother Res 1990; 4(6): 232–4CrossRef
117.
Tsuchiya T, Tanida M, Uenoyama S, et al. Effects of olfactory stimulation on the sleep time induced by pentobarbital administration in mice. Brain Res Bull 1991; 26: 397–401PubMedCrossRef
118.
Fujiwara R, Komori T, Mitsuo Y. Psychoneuroimmunological benefits of aromatherapy. Int J Aromather 2002; 12(2): 78–82CrossRef
119.
Carlini EA, de Oliveira AB, de Oliveria GG. Psychopharmacological effects of the essential oil fraction and of the hydrolate obtained from the seeds of Licaria puchury-major. J Ethnopharmacol 1983; 8: 225–36PubMedCrossRef
120.
Moreira MR, Cruz GM, Lopez MS, et al. Effects of terpineol on the compound action potential of the rate sciatic nerve. Braz J Med Biol Res 2001; 34: 1337–40PubMedCrossRef
121.
Aloisi AM, Ceccarelli I, Masi F, et al. Effects of the essential oil from citrus lemon in male and female rats exposed to a persistent painful stimulation. Behav Brain Res 2002; 136: 127–35PubMedCrossRef
122.
Ceccarelli L, Masi F, Fiorenzani P, et al. Sex differences in the citrus lemon essential oil-induced increase of hippocampal acetylcholine release in rats exposed to a persistent painful stimulation. Neurosci Lett 2002; 330: 25–8PubMedCrossRef
123.
Fujiwara R, Komori T, Noda Y, et al. Effects of a long-term inhalation of fragrances on the stress-induced immunosuppression in mice. Neuroimmunomod 1998; 5: 318–22CrossRef
124.
Lis-Balchin M, Hart S, Wan Hang Lo B. Jasmine absolute (Jasminum grandiflora L.) and its mode of action on guineapig ileum in vitro. Phytother Res 2002; 16: 437–9PubMedCrossRef
125.
Umezu T, Sakata A, Hiroyasu I. Ambulation-promoting effect of perppermint oil and identification of its active constituents. Pharmacol Biochem Behav 2001; 69: 383–90PubMedCrossRef
126.
Hohmann J, Zupko I, Redei D, et al. Protective effects of the aerial parts of Salvia officinalis,Melissa Officinalis and Lavandula angustifolia and their constituents against enzyme-dependent and enzyme-independent lipid peroxidation. Planta Med 1999; 65: 576–8PubMedCrossRef
127.
Perry NS, Houghton PJ, Theobald A, et al. In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol 2000; 52: 895–902PubMedCrossRef
128.
Garcia DA, Perillo MA, Zygadlo JA, et al. The essential oil from Tagetes minuta L. modulates the binding of [3H]flunitrazepam to crude membranes from chick brain. Lipids 1995; 30(12): 1105–10
129.
Marin RH, Garcia DA, Martijena ID, et al. Anxiogenic-like effects of Tagetes inuta L essential oil on T-maze and tonic immobility behaviour in domestic chicks. Fundam Clin Pharmacol 1998; 12: 426–32PubMedCrossRef
130.
Martijena ID, Garcia DA, Marin RH, et al. Anxiogenic-like and antidepressant-like effects of the essential oil from Tagetes minuta. Fitoterapia 1998; 2: 155–60
131.
Sugawara Y, Hara C, Aoki T, et al. Odor distinctiveness between enantiomers of linalool: difference in perception and responses elicited by sensory test and forehead surface potential wave measurement. Chem Senses 2000; 25: 77–84PubMedCrossRef
132.
Kirk-Smith M. The psychological effects of lavender I: scientific and clinical evidence. Int J Aromather 2003; 13(2/3): 82–9CrossRef
133.
Nasel C, Nasel B, Samec P, et al. Functional imaging of effects of fragrances on the human brain after prolonged inhalation. Chem Senses 1994; 19: 359–64PubMedCrossRef
134.
Hold KM, Sirisoma NS, Ikeda T, et al. Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proc Natl Acad Sci U S A 2000; 97: 3826–31PubMedCrossRef
135.
Jager W, Buchbauer G, Jirovetz L, et al. Evidence of the sedative effect of neroli oil, citronellal and phenylethyl acetate on mice. J Essent Oil Res 1992; 4: 387–94CrossRef
136.
Powers KA, Beasley VR. Toxicological aspects of linalool: a review. Vet Hum Toxiocol 1985; 27(6): 484–6
137.
Falk-Filipsson A, Lof A, Hagberg M, et al. d-limonene exposure to humans by inhalation: uptake, distribution, elimination, and effects on the pulmonary function. J Toxicol Environ Health 1993; 38: 77–88PubMedCrossRef
138.
Guedes DN, Silva DF, Barbosa-Filho JM, et al. Muscarinic agonist properties involved in the hypotensive and vasorelaxant responses of rotundifolone in rats. Planta Med 2002; 68(8): 700–4PubMedCrossRef
139.
Gamez MJ, Jimenez J, Navarro C, et al. Study of the essential oil of Lavandula dentata L. Pharmazie 1990; 45: 69–70PubMed
140.
Lahlou S, Galindo CAB, Leal-Cardoso JH, et al. Cardiovascular effects of the essential oil of Alpinia zerumbet leaves and its main constituent, terpinen-4-ol, in rats: role of the autonomic nervous system. Planta Med 2002; 68: 1092–6CrossRef
141.
Alexander M. Aromatherapy and immunity: how the use of essential oils aid immune potentiality. Int J Aromather 2001; 11(4): 220–4CrossRef
142.
Deans SG, Noble RC, Penzes L, et al. Promotional effects of plant volatile oils on the polyunsaturated fatty acid status during aging. Age 1993; 16: 71–4CrossRef
143.
De-Oliveira CAX, Ribeiro-Pinto LF, Paumgartten FJR. In vitro inhibition of CYP2B1 monooxygenase by beta-myrcene and other monoterpenoid compounds. Toxicol Lett 1997; 92: 39–46PubMedCrossRef
144.
Lis-Balchin M. Re: essential oils and ‘aromatherapy’ their modern role in healing. J R Soc Health 1998; 118: 126PubMedCrossRef
145.
Morris N. The effects of lavender (Lavendula angustifolium) baths on psychological well-being: two exploratory randomised control trials. Complement Ther Med 2002; 10: 223–8PubMedCrossRef
146.
Masago R, Matsuda T, Kikuchi Y, et al. Effects of inhalation of essential oils on EEG activity and sensory evaluation. J Physi-ol Anthropol Appl Human Sci 2000; 19: 35–42CrossRef
147.
Vernet-Maury E, Alaoui-Ismaili O, Dittmar A, et al. Basic emotions induced by odorants: a new approach based on autonomic pattern results. J Auton Nerv Syst 1999; 75: 176–83PubMedCrossRef
148.
Yagyu T. Neurophysiological findings on the effects of fragrance: lavender and jasmine. Integr Psychiatry 1994; 10: 62–7
149.
Nagai M, Wada M, Usui N, et al. Pleasant odors attenuate the blood pressure increase during rhythmic handgrip in humans. Neurosci Lett 2000; 289: 227–9PubMedCrossRef
150.
Horrawitz S. Aromatherapy: modern application of essential oils. Altern Complement Ther 1999, 203
151.
Lahlou S, Magalhaes PJC, Carneiro-Leao RFL, et al. Involvement of nitric oxide in the mediation of the hypotensive action of the essential oil of Mentha x villosa in normotensive conscious rats. Planta Med 2002; 68: 694–9PubMedCrossRef
Metadata
Title
Aromatherapy in the Management of Psychiatric Disorders
Clinical and Neuropharmacological Perspectives
Authors
Dr Nicolette Perry
Elaine Perry
Publication date
01-04-2006
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 4/2006
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-200620040-00001

Other articles of this Issue 4/2006

CNS Drugs 4/2006 Go to the issue

Commentary

The SOHO (Schizophrenia Outpatient Health Outcome) Study

Adis Drug Profile

Ziconotide

Original Research Article

Assessing Therapeutic Efficacy in a Progressive Disease

Adis Drug Profile

Ziconotide

Correspondence

Reports of Acute Angle Closure Glaucoma-Related Adverse Events with SSRIs: Results of a Disproportionality Analysis

Adis Drug Profile

Ziconotide